Model Based Fast Anatomical Mapping (MFAM)

November 7, 2023 updated by: Vivek Reddy

Left Atrial Anatomy Reconstruction Using Model Based Fast Anatomical Mapping

This prospective, multicenter observational study will examine the ability of model based fast anatomical mapping (mFAM) to create left atrial (LA) geometry for atrial fibrillation ablation.

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

This prospective, multicenter observational study will examine the ability of model based fast anatomical mapping (mFAM) to create left atrial (LA) geometry for atrial fibrillation ablation.

Specifically, the study will assess the following issues in atrial fibrillation ablation:

  1. Accuracy of map (defined as the distance between the ablation points and the surface of the mFAM geometry)
  2. Left atrial geometry creation time
  3. Fluoroscopy time

The clinical team will hypothesize that this approach will lead to accurate LA geometry creation more rapidly and using less fluoroscopy than standard techniques

Study Type

Interventional

Enrollment (Actual)

109

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10029
        • Icahn School of Medicine at Mount Sinai

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥ 18 years
  • Have AF as follows:

    1. Paroxysmal AF - defined as AF that is non-sustained (terminate without electrical or pharmacologic cardioversion) lasting < 7 days.
    2. Persistent AF - defined as AF that is sustained > 7 days. Episodes of AF which are terminated by electrical or pharmacologic cardioversion after ≥ 48 hours of AF, but prior to 7 days, should also be classified as persistent AF episodes.
  • Are planned to undergo a first catheter ablation procedure (prior typical atrial flutter is allowed)
  • Have the ability to understand the requirements of the study and sign the informed consent form.
  • Are willing to adhere to study restrictions and comply with all post-procedural follow-up requirements

Exclusion Criteria:

  • Rheumatic heart disease,
  • Current intra-cardiac thrombus
  • Class IV HF
  • Unable to sign consent
  • Unstable angina
  • Recent cerebral ischemic events
  • Contradiction to anticoagulation
  • Prior cardiac surgery
  • Complex congenital heart disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MFAM

The mFAM Workstation is a computerized system used to reconstruct the shape of the left atrium of the heart, by fitting a parametric shape model to points data acquired by a catheter.

The mFAM Workstation uses recorded catheter positions and other data inputs collected from various types of multi-electrode catheters and generates output data files that can be displayed as a 3D anatomic structure.

Specifically, the mFAM Workstation accesses stored data of recorded electronic heart activity that has been obtained by conventional electrophysiological methods, using multi-electrode catheters placed in the heart (data inputs) for collection. Using proprietary software algorithms, the mFAM Workstation analyzes these data inputs and generates 3D anatomical structure.

mFAM improves on the FAM functionality by applying a model-based approach for reconstruction of left atrial chamber anatomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mMap Scoring Questionnaire
Time Frame: hospital discharge, average 24 hours post procedure

mMap Scoring Questionnaire: Tool used by operators to rate the accuracy of the map based on the distance between ablation points and accuracy of anatomy compared to the mapped mFam geometry.

Total score from 1-7, with lower score indicating not representing (misleading) and higher score indicating agreement (accurate)

hospital discharge, average 24 hours post procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fluoroscopy Time
Time Frame: hospital discharge, average 24 hours post procedure
Fluoroscopy (radiation) time for left atrial anatomy creation during the ablation procedure
hospital discharge, average 24 hours post procedure
Left Atrial Geometry Creation Time
Time Frame: during the procedure up to 60 minutes
The amount of time it takes to create the geometrical map using Carto and MFAM during the ablation procedure
during the procedure up to 60 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Mohit Turagam, MD, Icahn School of Medicine at Mount Sinai
  • Study Chair: Vivek Reddy, MD, Icahn School of Medicine at Mount Sinai

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 16, 2018

Primary Completion (Actual)

October 3, 2022

Study Completion (Actual)

October 3, 2022

Study Registration Dates

First Submitted

November 17, 2017

First Submitted That Met QC Criteria

November 17, 2017

First Posted (Actual)

November 21, 2017

Study Record Updates

Last Update Posted (Actual)

November 29, 2023

Last Update Submitted That Met QC Criteria

November 7, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Paroxysmal Atrial Fibrillation

Subscribe